Employer record no. 9679
Juno Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2023
Total LCA filings
41
Certified
36
Denied
0
FY2023 filings
5
Filings by fiscal year
Peer rank
#777 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 17 | 13 | 0 | $124,056 | $87,118 |
| FY2021 | 8 | 8 | 0 | $122,432 | $95,319 |
| FY2022 | 11 | 11 | 0 | $126,133 | $88,510 |
| FY2023 | 5 | 4 | 0 | $115,570 | $88,945 |
What they file for
- manager qc microbiology$124,9103
- associate iii, quality control$86,1122
- associate scientist$101,2302
- associate scientist, cellular analytics$99,5002
- cell therapy media specialist, manufacturing$112,0002
- manager, senior scientist$118,7952
- principal scientist, cell therapy predictive sciences$177,8662
- senior specialist, product management$97,8502
Where
- seattle, wa21
- bothell, wa18
- los angeles, ca2
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Juno Therapeutics, Inc. and any other employer they watch.
Certification rate 87.8%How these numbers are computed